Home/Filings/4/0000902664-23-004790
4//SEC Filing

Caligan Partners LP 4

Accession 0000902664-23-004790

CIK 0001267602other

Filed

Sep 14, 8:00 PM ET

Accepted

Sep 15, 4:05 PM ET

Size

11.9 KB

Accession

0000902664-23-004790

Insider Transaction Report

Form 4
Period: 2023-09-14
Transactions
  • Sale

    Common Stock, par value 0.01 per share (Common Stock)

    2023-09-14$3.39/sh579,000$1,962,81016,256,154 total(indirect: See footnote)
  • Purchase

    Common Stock

    2023-09-14$3.39/sh+579,000$1,962,81016,835,154 total(indirect: See footnote)
  • OtherSwap

    Notional Derivative Agreements (obligation to buy)

    2023-09-14+1490,000 total(indirect: See footnote)
    Common Stock (490,000 underlying)
Transactions
  • Sale

    Common Stock, par value 0.01 per share (Common Stock)

    2023-09-14$3.39/sh579,000$1,962,81016,256,154 total(indirect: See footnote)
  • Purchase

    Common Stock

    2023-09-14$3.39/sh+579,000$1,962,81016,835,154 total(indirect: See footnote)
  • OtherSwap

    Notional Derivative Agreements (obligation to buy)

    2023-09-14+1490,000 total(indirect: See footnote)
    Common Stock (490,000 underlying)
Footnotes (3)
  • [F1]This Form 4 is filed by David Johnson ("Mr. Johnson") and Caligan Partners LP ("Caligan") with respect to the securities held by Caligan Partners Master Fund LP ("Caligan Master Fund"), a Cayman Islands limited partnership, and managed accounts ("Caligan Accounts", together with the Caligan Master Fund, the "Caligan Fund and Accounts") to which Caligan serves as investment manager. Mr. Johnson is the Managing Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan.
  • [F2]Represents rebalancing transaction between the Caligan Fund and Accounts.
  • [F3]At the market close on September 14, 2023, the expiration date of the notional principal amount derivative agreements in the form of cash settled swaps previously reported on the Form 3 filed by the Reporting Persons on August 11, 2023, was extended from February 2, 2024 to September 26, 2025.

Documents

1 file

Issuer

ALIMERA SCIENCES INC

CIK 0001267602

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001727492

Filing Metadata

Form type
4
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 4:05 PM ET
Size
11.9 KB